These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26681779)

  • 21. Pharmacology lessons from chemoprophylaxis studies.
    Boffito M; Jackson A; Asboe D
    Clin Infect Dis; 2014 Jul; 59 Suppl 1():S52-4. PubMed ID: 24926035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: a Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians.
    Palummieri A; De Carli G; Rosenthal É; Cacoub P; Mussini C; Puro V;
    BMC Infect Dis; 2017 Nov; 17(1):734. PubMed ID: 29179700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [PrEP Forum: an on-line debate on pre-exposure prophylaxis in Brazil].
    Queiroz AAFLN; Sousa AFL
    Cad Saude Publica; 2017 Nov; 33(11):e00112516. PubMed ID: 29166481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Key data from AIDS 2022.
    Owen R; Maan I; Waters L
    HIV Med; 2023 May; 24(5):515-520. PubMed ID: 36349523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influences of geo-spatial location on pre-exposure prophylaxis use in South Africa: positioning microbicides for better product uptake.
    Govender EM; Mansoor LE; Abdool Karim Q
    AIDS Care; 2017 Jun; 29(6):734-740. PubMed ID: 27799005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Injectable agents for pre-exposure prophylaxis: lessons learned from contraception to inform HIV prevention.
    Myers JE; Ellman TM; Westhoff C
    Curr Opin HIV AIDS; 2015 Jul; 10(4):271-7. PubMed ID: 26049953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergency Department-Based Human Immunodeficiency Virus Preexposure Prophylaxis Referral Program-Using Emergency Departments as a Portal for Preexposure Prophylaxis Services.
    Zhao Z; Jones J; Arrington-Sanders R; Gladfelter G; McDonald S; Reed C; Myer D; Schlenker N; Fulton G; Jones T; Saheed M; Rothman R; Hsieh YH
    Sex Transm Dis; 2021 Aug; 48(8):e102-e104. PubMed ID: 33433172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-serodiscordant couples desiring a child: 'treatment as prevention,' preexposure prophylaxis, or medically assisted procreation?
    Mabileau G; Schwarzinger M; Flores J; Patrat C; Luton D; Epelboin S; Mandelbrot L; Matheron S; Yazdanpanah Y
    Am J Obstet Gynecol; 2015 Sep; 213(3):341.e1-12. PubMed ID: 25979615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful Implementation of HIV Preexposure Prophylaxis: Lessons Learned From Three Clinical Settings.
    Marcus JL; Volk JE; Pinder J; Liu AY; Bacon O; Hare CB; Cohen SE
    Curr HIV/AIDS Rep; 2016 Apr; 13(2):116-24. PubMed ID: 26898645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hope for South Africa--at last.
    Lancet; 2003 Aug; 362(9383):501. PubMed ID: 12932376
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevention of HIV for persons with low-frequency, high-risk exposures: PrEP (preexposure prophylaxis), PEP (postexposure prophylaxis), or 'PIP' (postexposure prophylaxis in-pocket).
    Wood BR
    AIDS; 2020 Mar; 34(3):481-482. PubMed ID: 31996596
    [No Abstract]   [Full Text] [Related]  

  • 32. PrEP as a feature in the optimal landscape of combination HIV prevention in sub-Saharan Africa.
    McGillen JB; Anderson SJ; Hallett TB
    J Int AIDS Soc; 2016; 19(7(Suppl 6)):21104. PubMed ID: 27760682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug delivery strategies and systems for HIV/AIDS pre-exposure prophylaxis and treatment.
    Nelson AG; Zhang X; Ganapathi U; Szekely Z; Flexner CW; Owen A; Sinko PJ
    J Control Release; 2015 Dec; 219():669-680. PubMed ID: 26315816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vital Signs: Increased Medicaid Prescriptions for Preexposure Prophylaxis Against HIV infection--New York, 2012-2015.
    Laufer FN; O'Connell DA; Feldman I; ; Zucker HA
    MMWR Morb Mortal Wkly Rep; 2015 Nov; 64(46):1296-301. PubMed ID: 26606257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AIDS at 35: A midlife crisis.
    Wilson D; Whiteside A
    Afr J AIDS Res; 2016 Dec; 15(4):iii-vi. PubMed ID: 27974020
    [No Abstract]   [Full Text] [Related]  

  • 36. [Progress and new challenges. HIV: the cure moves closer].
    Leiner P
    MMW Fortschr Med; 2015 Feb; 157(2):29. PubMed ID: 25743508
    [No Abstract]   [Full Text] [Related]  

  • 37. A Cost-effectiveness Analysis of Preexposure Prophylaxis for the Prevention of HIV Among Los Angeles County Men Who Have Sex With Men.
    Drabo EF; Hay JW; Vardavas R; Wagner ZR; Sood N
    Clin Infect Dis; 2016 Dec; 63(11):1495-1504. PubMed ID: 27558571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urgent appeal to allow all professional nurses and midwives to prescribe pre-exposure prophylaxis (PrEP) in South Africa.
    Joseph Davey DL; Wilkinson L; Grimsrud A; Nelson A; Gray A; Raphael Y; Wattrus C; Pillay Y; Bekker LG
    S Afr Med J; 2023 Aug; 113(8):12-16. PubMed ID: 37882113
    [No Abstract]   [Full Text] [Related]  

  • 39. What does preexposure prophylaxis mean for treatment; what does treatment mean for preexposure prophylaxis?
    Venter WD
    Curr Opin HIV AIDS; 2016 Jan; 11(1):35-40. PubMed ID: 26545265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The History of the HIV/AIDS Epidemic in Africa.
    Kagaayi J; Serwadda D
    Curr HIV/AIDS Rep; 2016 Aug; 13(4):187-93. PubMed ID: 27188298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.